A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : pThr / phosphothreonine

[Related PubMed/MEDLINE]
Total Number of Papers: 30
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   pThr  (>> Co-occurring Abbreviation)
Long Form:   phosphothreonine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Outer-Sphere Control for Divergent Multicatalysis with Common Catalytic Moieties. CPA, Pmh
2019 Phosphothreonine (pThr)-Based Multifunctional Peptide Catalysis for Asymmetric Baeyer-Villiger Oxidations of Cyclobutanones. BV, CPAs, Dap
2019 Structural insights into the functional versatility of an FHA domain protein in mycobacterial signaling. FHA
2018 Advances in development of new tools for the study of phosphohistidine. pHis, pSer, pTyr
2018 Divergent Stereoselectivity in Phosphothreonine (pThr)-Catalyzed Reductive Aminations of 3-Amidocyclohexanones. ---
2018 Generating a recombinant phosphothreonine-binding domain for a phosphopeptide of the human transcription factor, c-Myc. FHA, Myc-pTBD, Ser62, Thr58
2017 Phosphatase-Stable Phosphoamino Acid Mimetics That Enhance Binding Affinities with the Polo-Box Domain of Polo-like Kinase 1. PBD, Plk1
2016 Selective Sensing of Tyrosine Phosphorylation in Peptides Using Terbium(III) Complexes. pSer, pTyr
2015 Phosphothreonine as a catalytic residue in peptide-mediated asymmetric transfer hydrogenations of 8-aminoquinolines. CPA
10  2015 Uncovering the Mechanism of Forkhead-Associated Domain-Mediated TIFA Oligomerization That Plays a Central Role in Immune Responses. FHA, NF-kappaB, TIFA
11  2014 Achieving peptide binding specificity and promiscuity by loops: case of the forkhead-associated domain. FHA, MD
12  2014 Design and synthesis of Fmoc-Thr[PO(OH)(OPOM)] for the preparation of peptide prodrugs containing phosphothreonine in fully protected form. ---
13  2014 Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells. PBDs, Plk1, POM, pSer
14  2013 Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form. POM
15  2013 Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs. PBDs, Plk1, POM, pSer
16  2012 An engineered lantipeptide synthetase serves as a general leader peptide-dependent kinase. PSer
17  2011 Mechanism of PhosphoThreonine/Serine Recognition and Specificity for Modular Domains from All-atom Molecular Dynamics. FHA, MD, pSer
18  2011 Rapid analysis of phosphoamino acids from phosvitin by near-infrared cyanine 1-(epsilon-succinimydyl-hexanoate)-1'-methyl-3,3,3',3'-tetramethyl-indocarbocyanine-5,5'-disulfonate potassium derivatization and polyacrylamide-coated CE with LIF detection. MeCy5-OSu, pSer, pTyr
19  2008 Structure and function of the phosphothreonine-specific FHA domain. FHA, pSer
20  2007 Liquid chromatographic analysis of phosphoamino acids at femtomole level using chemical derivatization with N-hydroxysuccinimidyl fluorescein-O-acetate. CE-LIF, FLD, HPLC, pSer, pTyr
21  2006 Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1. CTD, Pol II, pSer
22  2005 Iodoacetamide-alkylated methionine can mimic neutral loss of phosphoric acid from phosphopeptides as exemplified by nano-electrospray ionization quadrupole time-of-flight parent ion scanning. camMet, IAA, MS/MS, pSer, QTOF
23  2003 Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. CDKs, PBD, Plk1, pSer
24  2002 Mutation of conserved active-site threonine residues in creatine kinase affects autophosphorylation and enzyme kinetics. ---
25  2002 Role of Ptc2 type 2C Ser/Thr phosphatase in yeast high-osmolarity glycerol pathway inactivation. MAPK
26  2000 Structural basis for phosphoserine-proline recognition by group IV WW domains. CTD, PPIase, pSer
27  1993 Preparation of anti-phosphoserine and anti-phosphothreonine antibodies and their application in the study of insulin- and EGF-induced phosphorylation. EGF, pSer
28  1988 Phosphotyrosine phosphatase activity of human and canine acid phosphatases of prostatic origin. AP, p-NPP, PAP, Pase, pSer, pTyr
29  1987 Comparison of the phosphorylation events in membranes from proliferating vs. quiescent endothelial cells. EC, pSer
30  1984 Preparation and characterization of antibodies to O-phosphotyrosine and their use for identification of phosphotyrosine-containing proteins. pSer, pTyr, RSV